Eqvalan Gold 7.75 % Paste is a Health Canada–registered veterinary drug (DIN 02290162) held by Boehringer Ingelheim Animal Health Canada Inc., containing Praziquantel. Health Canada lists its status as Marketed (status date 27 Nov 2019). Nexara Health has matched 53 registrations of Praziquantel across 21 other regulated markets.

Health Canada registration

Praziquantel registered in other markets

53 registrations of the same molecule in 21 national registries outside Canada (first 45 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.

See every manufacturer of Praziquantel worldwide →

Regulator price references for Praziquantel

Published list or reimbursement prices for Praziquantel presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.

Related molecules (ATC QP54A)

• Ivermectin

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. Because this DIN is marketed in Canada, supply normally comes through the Canadian channel; where the Canadian presentation is short or discontinued, the registrations above show which regulated markets hold an equivalent that can be imported under the Special Access Programme or for clinical comparator use. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Eqvalan Gold (DIN 02290162) marketed in Canada?

Yes. Health Canada lists DIN 02290162 as Marketed as of 27 Nov 2019.

Who holds the Canadian licence for this product?

Boehringer Ingelheim Animal Health Canada Inc. is the company of record in the Health Canada Drug Product Database.

Is Praziquantel registered outside Canada?

Yes — Nexara Health has matched 53 registrations in 21 other markets (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 02290162, status date 2019-11-27; national medicine registries: CMED, CSG Compendio (formulary), DH Drug Office, DoH SEP database, EMA centrally authorised, EU national register, FDA NDC, FEST (DMP), HSA, HZZO, Laegemiddelstyrelsen, LINAME (formulary), Lyfjastofnun lyfjaverdskra, Medicines Authority, NHS dm+d VMP, PAMI, PBS, SFDA, SUKL DLP, TFDA, URPL RPL; price sources: CMED, DoH SEP database, Lyfjastofnun lyfjaverdskra, PBS, SFDA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 02290162, status date 2019-11-27; national medicine registries: CMED, CSG Compendio (formulary), DH Drug Office, DoH SEP database, EMA centrally authorised, EU national register, FDA NDC, FEST (DMP), HSA, HZZO, Laegemiddelstyrelsen, LINAME (formulary), Lyfjastofnun lyfjaverdskra, Medicines Authority, NHS dm+d VMP, PAMI, PBS, SFDA, SUKL DLP, TFDA, URPL RPL; price sources: CMED, DoH SEP database, Lyfjastofnun lyfjaverdskra, PBS, SFDA.

Health Canada Drug Product Database (DPD), DIN 02290162, status date 2019-11-27; national medicine registries: CMED, CSG Compendio (formulary), DH Drug Office, DoH SEP database, EMA centrally authorised, EU national register, FDA NDC, FEST (DMP), HSA, HZZO, Laegemiddelstyrelsen, LINAME (formulary), Lyfjastofnun lyfjaverdskra, Medicines Authority, NHS dm+d VMP, PAMI, PBS, SFDA, SUKL DLP, TFDA, URPL RPL; price sources: CMED, DoH SEP database, Lyfjastofnun lyfjaverdskra, PBS, SFDA. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.